Results & Expectations

What Happens When You Stop

Learn what happens when you stop Mounjaro or Wegovy, including appetite changes, weight regain, and how to manage the transition.

Whether you are at the NHS Wegovy 2-year cap, considering stopping privately for cost or other reasons, or just trying to understand what happens long-term, this guide covers what the published evidence shows about life after stopping Mounjaro or Wegovy. Different from our stopping safely guide — which covers how to stop — this page focuses on what to expect over the months and years that follow. LetsLoseWeight is an independent comparison site; we do not prescribe medication.

The headline finding

The most-cited evidence on what happens after stopping comes from the STEP 1 trial extension — researchers followed participants from the original semaglutide weight-loss trial for a year after stopping the medicine. The result: on average, participants regained around two-thirds of the weight they had lost within 12 months of stopping (Wilding et al., 2022).

Two-thirds is the average. Some patients regained less; some regained more. The pattern is consistent with a treatment that works while you take it and stops working when you don't.

This isn't unique to Mounjaro and Wegovy — the same regain pattern is seen across most weight-loss treatments (diet, exercise, even bariatric surgery to a lesser degree). Obesity behaves like a chronic condition rather than a time-limited problem to fix.

The phases of post-stopping experience

Drawing from STEP 1 trial extension data and clinical experience, the typical post-stopping trajectory looks like this:

Weeks 1–4 — appetite returns

The most striking change. Hunger and food cravings come back, often noticeably. Patients describe:

  • "Food noise" returning — constant background thoughts about what to eat
  • Feeling less full after meals
  • Wanting to snack more
  • Cravings for previously-uninteresting foods returning

This is the medicine's effect on appetite-regulating brain pathways fading. By 4 weeks, appetite is usually back near pre-treatment levels.

Months 1–6 — most rapid regain

The steepest part of the regain curve. Patients who don't actively manage eating and activity through this phase tend to regain a meaningful proportion of their lost weight in this window.

What predicts regaining slower in this phase:

  • Continued physical activity at near pre-stopping levels
  • Maintained dietary structure — meal timing, protein intake, portion control
  • Self-monitoring — weekly weighing, catching regain early
  • Continued behavioural support if accessed during treatment

What predicts regaining faster:

  • Returning to pre-treatment eating patterns wholesale
  • Dropping activity levels ("I can relax now the medicine is gone")
  • Hidden snacking and increased portions that compensate for returning appetite
  • Stopping all monitoring

Months 6–12 — regain slows but continues

Most patients are still regaining at 6 months but at a slower rate than months 1–6. The body is finding a new equilibrium between the lost-weight set point and the pre-treatment set point.

By 12 months, the STEP 1 extension data shows participants had regained about two-thirds of lost weight on average. Importantly, this means about one-third of the weight loss was retained — which is more than most other weight-loss interventions show at the same time point.

Beyond 12 months — variable

Less data exists for the longer term. Clinical experience suggests:

  • Some patients reach a stable weight near (but slightly below) their pre-treatment weight within 18–24 months
  • Some patients continue to regain until they exceed pre-treatment weight (the "rebound" phenomenon, more common after very rapid weight loss)
  • A minority maintain a meaningful proportion of the loss long-term through sustained lifestyle changes

The longer-term picture depends heavily on what happens in the first year after stopping. Lifestyle changes that have become embedded by the end of treatment carry forward; lifestyle changes that haven't, don't.

What changes besides weight

Stopping the medicines doesn't just affect weight. The cardiometabolic improvements that came with weight loss tend to reverse on a similar timeline.

Blood pressure

Improvements during treatment (typically a 5–8 mmHg reduction in systolic BP) tend to fade as weight regain progresses. Within 12 months of stopping, blood pressure often returns close to pre-treatment levels.

Blood sugar (in type 2 diabetes)

For people with type 2 diabetes, HbA1c improvements during treatment typically reverse within 6–12 months of stopping. Other diabetes medicines may need adjustment to maintain control.

Cholesterol and lipids

Improvements in triglycerides and HDL tend to fade with weight regain. The pattern is not as consistent as blood pressure or blood sugar — some lipid improvements persist longer.

Sleep apnoea

Improvements in apnoea severity that came with weight loss often hold for some months after stopping but may worsen if substantial regain occurs.

Joint pain and physical function

Often the slowest to reverse. Patients who maintained mobility and activity during weight loss may keep functional improvements even with some regain.

Why the regain happens

Several biological factors explain why stopping leads to regain:

Loss of GLP-1 (and GIP, for Mounjaro) signalling

The appetite-suppressing effect that drove the weight loss disappears within weeks of stopping. Hunger returns to baseline.

Metabolic adaptation persists

The body's resting energy expenditure adapts to lower weight by burning fewer calories at rest — and this adaptation persists for months or years after weight loss, making maintenance harder than starting weight would predict.

Hormonal changes

Leptin (a satiety hormone) drops with weight loss and stays low even after stopping medicine. Ghrelin (a hunger hormone) increases. Both drive increased appetite.

Behavioural patterns

Many lifestyle adjustments made during treatment are partially or fully sustained by the medicine's effect. Without that scaffolding, behaviours often drift back to pre-treatment patterns.

This is not a failure of willpower — it's biology. Understanding it helps set realistic expectations and identify the strategies that actually help.

Patients who regain less

Across studies and clinical experience, several factors are associated with regaining less:

Lifestyle changes that became habits

If your eating, activity, and sleep patterns meaningfully changed during treatment and feel sustainable without medication, they will continue to support maintenance. Patients who relied on the medicine alone, without changing other habits, regain faster.

Continued physical activity

Especially resistance training, which preserves muscle and supports metabolic rate. Aerobic activity (walking, cycling) supports calorie balance and cardiovascular health.

Continued protein-prioritised eating

The 1.2–1.6g per kg body weight per day target during weight loss is also useful for maintenance. Adequate protein supports muscle, sense of fullness, and metabolic rate.

Self-monitoring

Weekly weighing, brief food logs when needed, and noticing trends early. Catching a 2kg gain is easier to act on than a 10kg gain.

Behavioural support

NHS Tier 3 weight management services and some private providers offer ongoing maintenance programmes. Cognitive-behavioural support has evidence for sustained outcomes.

Restarting if appropriate

For patients whose regain is rapid and substantial, restarting the medicine is a legitimate option. See our restarting guide.

What this means for treatment planning

The post-stopping picture is increasingly part of the conversation at the start of treatment, not just at the end:

  • Treatment is generally framed as long-term, similar to medicines for blood pressure or cholesterol
  • NHS Wegovy's 2-year cap under TA875 has been a recurring concern because of the regain pattern
  • NHS Mounjaro under TA1026 does not carry the same cap — long-term continuation is possible
  • Private treatment has no fixed time limit; cost is the main barrier to continuation

For many patients, the realistic plan is "continue indefinitely while it remains clinically appropriate" rather than "stop after a defined period and maintain through diet and exercise alone".

Frequently asked questions

Will I regain everything I lost?
On average, no — about two-thirds of lost weight is regained within 12 months according to the STEP 1 extension. Some patients keep more, some less.

How quickly does regain start?
Most patients notice appetite changes within 1–2 weeks of stopping. Measurable regain often shows in the 4–8 week range. Most rapid regain is in months 1–6.

Can I avoid regain entirely?
A small minority of patients do. The factors that distinguish them are continued lifestyle changes, particularly physical activity and protein intake, and active self-monitoring. Most patients regain at least some weight even with strong maintenance efforts.

Is the medicine "just" delaying the inevitable then?
That's one framing. Another is that the medicine produces real benefits while taken (cardiovascular, metabolic, functional, quality-of-life) that may be worth having even if not permanent. The same logic applies to medicines for blood pressure or cholesterol — they don't "cure" the underlying condition, but they meaningfully change the trajectory while taken.

Should I try to lose more weight after stopping to compensate for expected regain?
No — this generally backfires. Aggressive losing-then-stopping cycles tend to produce worse outcomes than steadier losing followed by sustained maintenance.

What's the longest-term data we have?
The STEP 1 extension was 12 months post-stopping. Longer-term post-stopping data is limited and gradually accumulating. Most published trials have run continuous treatment for 1–2 years rather than treatment-then-stop sequences.

Next steps

Sources

This guide is for general information only and is not a substitute for professional medical advice. Decisions about stopping treatment should be made with your prescriber.

Get weekly weight loss tips

Join our newsletter for provider updates, expert guidance, and exclusive offers — no spam.

Subscribe free
Back to Guides
What Happens When You Stop Mounjaro or Wegovy UK | LetsLoseWeight